Dancann Pharma

About:

Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.

Top Investors: Nordic Growth

Description:

Streaks AI is a leading developer of conversational AI platforms, pioneering innovative solutions for seamless and interactive communication. Specialising in creating advanced conversational interfaces, Streaks AI leverages artificial intelligence to enhance user experiences across various industries.

Total Funding Amount:

35.6M DKK

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ansager, Syddanmark, Denmark

Founded Date:

2018-01-01

Contact Email:

info(AT)dancann.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-06-27

IPO Status:

Public

Industries: